{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:52:07Z","timestamp":1790488327689,"version":"4.1.0"},"reference-count":59,"publisher":"Rockefeller University Press","issue":"7","content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,7,2]]},"abstract":"<jats:p>Pseudomonas aeruginosa is a leading cause of hospital-associated infections in the seriously ill, and the primary agent of chronic lung infections in cystic fibrosis patients. A major obstacle to effective control of P. aeruginosa infections is its intrinsic resistance to most antibiotic classes, which results from chromosomally encoded drug-efflux systems and multiple acquired resistance mechanisms selected by years of aggressive antibiotic therapy. These factors demand new strategies and drugs to prevent and treat P. aeruginosa infections. Herein, we describe a monoclonal antibody (mAb) selection strategy on whole P. aeruginosa cells using single-chain variable fragment phage libraries derived from healthy individuals and patients convalescing from P. aeruginosa infections. This approach enabled identification of mAbs that bind three distinct epitopes on the product of the Psl. This exopolysaccharide is important for P. aeruginosa attachment to mammalian cells, and for the formation and maintenance of biofilms produced by nonmucoid and mucoid P. aeruginosa isolates. Functional screens revealed that mAbs to one epitope exhibit superior activity in opsonophagocytic killing and cell attachment assays, and confer significant protection in multiple animal models. Our results indicate that Psl is an accessible serotype-independent surface feature and promising novel protective antigen for preventing P. aeruginosa infections. Furthermore, our mAb discovery strategy holds promise for application to other bacterial pathogens.<\/jats:p>","DOI":"10.1084\/jem.20120033","type":"journal-article","created":{"date-parts":[[2012,6,26]],"date-time":"2012-06-26T18:30:29Z","timestamp":1340735429000},"page":"1273-1287","update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":168,"title":["Identification of broadly protective human antibodies to<i>Pseudomonas aeruginosa<\/i>exopolysaccharide Psl by phenotypic screening"],"prefix":"10.1084","volume":"209","author":[{"given":"Antonio","family":"DiGiandomenico","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and 1 2"},{"name":"Antibody Discovery and Protein Engineering, MedImmune, LLC, Gaithersburg, MD 20878 1 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Warrener","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and 1 2"},{"name":"Antibody Discovery and Protein Engineering, MedImmune, LLC, Gaithersburg, MD 20878 1 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and 1 2"},{"name":"Antibody Discovery and Protein Engineering, MedImmune, LLC, Gaithersburg, MD 20878 1 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Guillard","sequence":"additional","affiliation":[{"name":"Antibody Discovery and Protein Engineering, MedImmune, Ltd, Granta Park, Cambridge CB21 6GH, England, UK 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ravn","sequence":"additional","affiliation":[{"name":"Antibody Discovery and Protein Engineering, MedImmune, Ltd, Granta Park, Cambridge CB21 6GH, England, UK 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Minter","sequence":"additional","affiliation":[{"name":"Antibody Discovery and Protein Engineering, MedImmune, Ltd, Granta Park, Cambridge CB21 6GH, England, UK 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Margarita","family":"Camara","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and 1 2"},{"name":"Antibody Discovery and Protein Engineering, MedImmune, LLC, Gaithersburg, MD 20878 1 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh","family":"Venkatraman","sequence":"additional","affiliation":[{"name":"Antibody Discovery and Protein Engineering, MedImmune, Ltd, Granta Park, Cambridge CB21 6GH, England, UK 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall S.","family":"MacGill","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and 1 2"},{"name":"Antibody Discovery and Protein Engineering, MedImmune, LLC, Gaithersburg, MD 20878 1 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and 1 2"},{"name":"Antibody Discovery and Protein Engineering, MedImmune, LLC, Gaithersburg, MD 20878 1 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and 1 2"},{"name":"Antibody Discovery and Protein Engineering, MedImmune, LLC, Gaithersburg, MD 20878 1 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley Elaine","family":"Keller","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and 1 2"},{"name":"Antibody Discovery and Protein Engineering, MedImmune, LLC, Gaithersburg, MD 20878 1 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica C.","family":"Bonnell","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and 1 2"},{"name":"Antibody Discovery and Protein Engineering, MedImmune, LLC, Gaithersburg, MD 20878 1 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mladen","family":"Tomich","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and 1 2"},{"name":"Antibody Discovery and Protein Engineering, MedImmune, LLC, Gaithersburg, MD 20878 1 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Jermutus","sequence":"additional","affiliation":[{"name":"Antibody Discovery and Protein Engineering, MedImmune, Ltd, Granta Park, Cambridge CB21 6GH, England, UK 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"McCarthy","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and 1 2"},{"name":"Antibody Discovery and Protein Engineering, MedImmune, LLC, Gaithersburg, MD 20878 1 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Melnick","sequence":"additional","affiliation":[{"name":"Infection Emerging Products, AstraZeneca Pharmaceuticals LP, Wilmington, DE 19803 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnn A.","family":"Suzich","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and 1 2"},{"name":"Antibody Discovery and Protein Engineering, MedImmune, LLC, Gaithersburg, MD 20878 1 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Kendall","family":"Stover","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and 1 2"},{"name":"Antibody Discovery and Protein Engineering, MedImmune, LLC, Gaithersburg, MD 20878 1 2"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2012,6,25]]},"reference":[{"key":"2023072602515721200_bib1","doi-asserted-by":"publisher","first-page":"14336","DOI":"10.1073\/pnas.0805942105","article-title":"Isolation of human monoclonal antibodies by mammalian cell display","volume":"105","author":"Beerli","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2023072602515721200_bib2","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/j.1365-2958.2009.06991.x","article-title":"Pseudomonas aeruginosa uses a cyclic-di-GMP-regulated adhesin to reinforce the biofilm extracellular matrix","volume":"75","author":"Borlee","year":"2010","journal-title":"Mol. Microbiol."},{"key":"2023072602515721200_bib3","doi-asserted-by":"publisher","first-page":"945","DOI":"10.2174\/1381612033455189","article-title":"Immune therapy for infectious diseases at the dawn of the 21st century: the past, present and future role of antibody therapy, therapeutic vaccination and biological response modifiers","volume":"9","author":"Buchwald","year":"2003","journal-title":"Curr. Pharm. Des."},{"key":"2023072602515721200_bib4","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1086\/318075","article-title":"Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis","volume":"183","author":"Burns","year":"2001","journal-title":"J. Infect. Dis."},{"key":"2023072602515721200_bib5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1365-2958.2009.06795.x","article-title":"Genetic and biochemical analyses of the Pseudomonas aeruginosa Psl exopolysaccharide reveal overlapping roles for polysaccharide synthesis enzymes in Psl and LPS production","volume":"73","author":"Byrd","year":"2009","journal-title":"Mol. Microbiol."},{"key":"2023072602515721200_bib6","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1128\/IAI.00057-11","article-title":"Direct evaluation of Pseudomonas aeruginosa biofilm mediators in a chronic infection model","volume":"79","author":"Byrd","year":"2011","journal-title":"Infect. Immun."},{"key":"2023072602515721200_bib7","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1128\/AEM.72.4.3066-3068.2006","article-title":"PslD is a secreted protein required for biofilm formation by Pseudomonas aeruginosa","volume":"72","author":"Campisano","year":"2006","journal-title":"Appl. Environ. Microbiol."},{"key":"2023072602515721200_bib8","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1128\/AAC.38.8.1695","article-title":"Serum therapy revisited: animal models of infection and development of passive antibody therapy","volume":"38","author":"Casadevall","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"2023072602515721200_bib9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/clinids\/21.1.150","article-title":"Return to the past: the case for antibody-based therapies in infectious diseases","volume":"21","author":"Casadevall","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"2023072602515721200_bib10","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nmeth765","article-title":"A Tn7-based broad-range bacterial cloning and expression system","volume":"2","author":"Choi","year":"2005","journal-title":"Nat. Methods."},{"key":"2023072602515721200_bib11","doi-asserted-by":"publisher","first-page":"e1001264","DOI":"10.1371\/journal.ppat.1001264","article-title":"The pel polysaccharide can serve a structural and protective role in the biofilm matrix of Pseudomonas aeruginosa","volume":"7","author":"Colvin","year":"2011","journal-title":"PLoS Pathog."},{"key":"2023072602515721200_bib12","doi-asserted-by":"publisher","first-page":"7012","DOI":"10.1128\/IAI.72.12.7012-7021.2004","article-title":"Oral vaccination of BALB\/c mice with Salmonella enterica serovar Typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model","volume":"72","author":"DiGiandomenico","year":"2004","journal-title":"Infect. Immun."},{"key":"2023072602515721200_bib13","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1073\/pnas.0608657104","article-title":"Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections","volume":"104","author":"DiGiandomenico","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2023072602515721200_bib14","first-page":"983","article-title":"Parenteral application of a Pseudomonas aeruginosa flagella vaccine elicits specific anti-flagella antibodies in the airways of healthy individuals","volume":"151","author":"D\u00f6ring","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2023072602515721200_bib15","doi-asserted-by":"publisher","first-page":"11020","DOI":"10.1073\/pnas.0702403104","article-title":"A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients","volume":"104","author":"D\u00f6ring","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2023072602515721200_bib16","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1038\/nbt1206-1497","article-title":"Antibacterial discovery and development\u2014the failure of success?","volume":"24","author":"Fernandes","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"2023072602515721200_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fmicb.2011.00167","article-title":"Biosynthesis of the Pseudomonas aeruginosa Extracellular Polysaccharides, Alginate, Pel, and Psl","volume":"2","author":"Franklin","year":"2011","journal-title":"Front Microbiol."},{"key":"2023072602515721200_bib18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1046\/j.1365-2958.2003.03877.x","article-title":"Genes involved in matrix formation in Pseudomonas aeruginosa PA14 biofilms","volume":"51","author":"Friedman","year":"2004","journal-title":"Mol. Microbiol."},{"key":"2023072602515721200_bib19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1021\/mp900236t","article-title":"Inhibition of tumor metastasis: functional immune modulation of the CUB domain containing protein 1","volume":"7","author":"Fukuchi","year":"2010","journal-title":"Mol. Pharm."},{"key":"2023072602515721200_bib20","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.1128\/AEM.00637-11","article-title":"Role of exopolysaccharides in Pseudomonas aeruginosa biofilm formation and architecture","volume":"77","author":"Ghafoor","year":"2011","journal-title":"Appl. Environ. Microbiol."},{"key":"2023072602515721200_bib21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/iai.42.1.170-177.1983","article-title":"Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains","volume":"42","author":"Hancock","year":"1983","journal-title":"Infect. Immun."},{"key":"2023072602515721200_bib22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0378-1119(98)00130-9","article-title":"A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants","volume":"212","author":"Hoang","year":"1998","journal-title":"Gene."},{"key":"2023072602515721200_bib23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.ijmm.2010.08.008","article-title":"Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung","volume":"300","author":"Hogardt","year":"2010","journal-title":"Int. J. Med. Microbiol."},{"key":"2023072602515721200_bib24","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-2958.2010.07320.x","article-title":"Pseudomonas aeruginosa biofilm matrix polysaccharide Psl is regulated transcriptionally by RpoS and post-transcriptionally by RsmA","volume":"78","author":"Irie","year":"2010","journal-title":"Mol. Microbiol."},{"key":"2023072602515721200_bib25","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.1128\/JB.186.14.4466-4475.2004","article-title":"Identification of psl, a locus encoding a potential exopolysaccharide that is essential for Pseudomonas aeruginosa PAO1 biofilm formation","volume":"186","author":"Jackson","year":"2004","journal-title":"J. Bacteriol."},{"key":"2023072602515721200_bib26","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1128\/AAC.00226-11","article-title":"Emergence of NDM-1 metallo-\u03b2-lactamase in Pseudomonas aeruginosa clinical isolates from Serbia","volume":"55","author":"Jovcic","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"2023072602515721200_bib27","doi-asserted-by":"crossref","first-page":"11291","DOI":"10.1016\/S0021-9258(18)37956-0","article-title":"Structure of an extracellular cross-reactive polysaccharide from Pseudomonas aeruginosa immunotype 4","volume":"263","author":"Kocharova","year":"1988","journal-title":"J. Biol. Chem."},{"key":"2023072602515721200_bib28","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1159\/000321018","article-title":"Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections","volume":"56","author":"Kunz","year":"2010","journal-title":"Chemotherapy."},{"key":"2023072602515721200_bib29","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.2174\/138161207782110408","article-title":"The targets of currently used antibacterial agents: lessons for drug discovery","volume":"13","author":"Lange","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"2023072602515721200_bib30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/protein\/gzn058","article-title":"Modelling the human immune response: performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens","volume":"22","author":"Lloyd","year":"2009","journal-title":"Protein Eng. Des. Sel."},{"key":"2023072602515721200_bib31","doi-asserted-by":"publisher","first-page":"e1000354","DOI":"10.1371\/journal.ppat.1000354","article-title":"Assembly and development of the Pseudomonas aeruginosa biofilm matrix","volume":"5","author":"Ma","year":"2009","journal-title":"PLoS Pathog."},{"key":"2023072602515721200_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/j.1574-695X.2012.00934.x","article-title":"The roles of biofilm matrix polysaccharide Psl in mucoid Pseudomonas aeruginosa biofilms","author":"Ma","year":"2012","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"2023072602515721200_bib33","doi-asserted-by":"publisher","first-page":"8377","DOI":"10.1073\/pnas.90.18.8377","article-title":"Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients","volume":"90","author":"Martin","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2023072602515721200_bib34","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.1128\/JB.186.14.4449-4456.2004","article-title":"Putative exopolysaccharide synthesis genes influence Pseudomonas aeruginosa biofilm development","volume":"186","author":"Matsukawa","year":"2004","journal-title":"J. Bacteriol."},{"key":"2023072602515721200_bib35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1462-5822.2011.01704.x","article-title":"Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization","volume":"14","author":"Mishra","year":"2012","journal-title":"Cell. Microbiol."},{"key":"2023072602515721200_bib36","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1111\/j.1462-2920.2011.02595.x","article-title":"The Pseudomonas aeruginosa sensor RetS switches type III and type VI secretion via c-di-GMP signalling","volume":"13","author":"Moscoso","year":"2011","journal-title":"Environ. Microbiol."},{"key":"2023072602515721200_bib37","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.burns.2004.09.002","article-title":"Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge","volume":"31","author":"Neely","year":"2005","journal-title":"Burns."},{"key":"2023072602515721200_bib38","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1107\/S0907444908007877","article-title":"Structural characterization of a human Fc fragment engineered for lack of effector functions","volume":"64","author":"Oganesyan","year":"2008","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2023072602515721200_bib39","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1128\/AEM.71.8.4407-4413.2005","article-title":"Expression of the psl operon in Pseudomonas aeruginosa PAO1 biofilms: PslA performs an essential function in biofilm formation","volume":"71","author":"Overhage","year":"2005","journal-title":"Appl. Environ. Microbiol."},{"key":"2023072602515721200_bib40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrd2201","article-title":"Drugs for bad bugs: confronting the challenges of antibacterial discovery","volume":"6","author":"Payne","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"2023072602515721200_bib41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0378-1119(96)00628-2","article-title":"An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries","volume":"187","author":"Persic","year":"1997","journal-title":"Gene."},{"key":"2023072602515721200_bib42","article-title":"Serotypes and immune responses to Pseudomonas aeruginosa","author":"Pier","year":"1986"},{"key":"2023072602515721200_bib43","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.4049\/jimmunol.173.9.5671","article-title":"Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains","volume":"173","author":"Pier","year":"2004","journal-title":"J. Immunol."},{"key":"2023072602515721200_bib44","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1172\/JCI109300","article-title":"Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man","volume":"63","author":"Pollack","year":"1979","journal-title":"J. Clin. Invest."},{"key":"2023072602515721200_bib45","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1128\/IAI.70.8.4158-4164.2002","article-title":"Generation and characterization of human monoclonal scFv antibodies against Helicobacter pylori antigens","volume":"70","author":"Reiche","year":"2002","journal-title":"Infect. Immun."},{"key":"2023072602515721200_bib46","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.mib.2007.09.010","article-title":"Role of polysaccharides in Pseudomonas aeruginosa biofilm development","volume":"10","author":"Ryder","year":"2007","journal-title":"Curr. Opin. Microbiol."},{"key":"2023072602515721200_bib47","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1093\/emboj\/cdg290","article-title":"The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU","volume":"22","author":"Sato","year":"2003","journal-title":"EMBO J."},{"key":"2023072602515721200_bib48","doi-asserted-by":"publisher","first-page":"e18356","DOI":"10.1371\/journal.pone.0018356","article-title":"Modified needle-tip PcrV proteins reveal distinct phenotypes relevant to the control of type III secretion and intoxication by Pseudomonas aeruginosa","volume":"6","author":"Sato","year":"2011","journal-title":"PLoS ONE."},{"key":"2023072602515721200_bib49","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/7391","article-title":"Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury","volume":"5","author":"Sawa","year":"1999","journal-title":"Nat. Med."},{"issue":"Suppl 6","key":"2023072602515721200_bib50","doi-asserted-by":"publisher","first-page":"G38","DOI":"10.1016\/j.vaccine.2009.09.105","article-title":"Monoclonal antibody-based therapies for microbial diseases","volume":"27","author":"Saylor","year":"2009","journal-title":"Vaccine."},{"key":"2023072602515721200_bib51","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1111\/j.1365-2958.1992.tb01558.x","article-title":"Allelic exchange in Pseudomonas aeruginosa using novel ColE1-type vectors and a family of cassettes containing a portable oriT and the counter-selectable Bacillus subtilis sacB marker","volume":"6","author":"Schweizer","year":"1992","journal-title":"Mol. Microbiol."},{"key":"2023072602515721200_bib52","first-page":"831","article-title":"Small broad-host-range gentamycin resistance gene cassettes for site-specific insertion and deletion mutagenesis","volume":"15","author":"Schweizer","year":"1993","journal-title":"Biotechniques."},{"key":"2023072602515721200_bib53","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/35023079","article-title":"Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen","volume":"406","author":"Stover","year":"2000","journal-title":"Nature."},{"key":"2023072602515721200_bib54","doi-asserted-by":"publisher","first-page":"7799","DOI":"10.1128\/JVI.00318-06","article-title":"Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo","volume":"80","author":"Ulbrandt","year":"2006","journal-title":"J. Virol."},{"key":"2023072602515721200_bib55","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1146\/annurev.immunol.20.103001.114744","article-title":"Phagocytosis of microbes: complexity in action","volume":"20","author":"Underhill","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"2023072602515721200_bib56","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nbt0396-309","article-title":"Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library","volume":"14","author":"Vaughan","year":"1996","journal-title":"Nat. Biotechnol."},{"key":"2023072602515721200_bib57","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nature06890","article-title":"Rapid cloning of high-affinity human monoclonal antibodies against influenza virus","volume":"453","author":"Wrammert","year":"2008","journal-title":"Nature."},{"key":"2023072602515721200_bib58","doi-asserted-by":"crossref","DOI":"10.1111\/j.1574-695X.2012.00936.x","article-title":"Polysaccharides serve as scaffold of biofilms formed by mucoid Pseudomonas aeruginosa","author":"Yang","year":"2012","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"2023072602515721200_bib59","first-page":"550","article-title":"Human single-chain Fv antibodies against Burkholderia mallei and Burkholderia pseudomallei","volume":"232","author":"Zou","year":"2007","journal-title":"Exp. Biol. Med. (Maywood)."}],"container-title":["Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/209\/7\/1273\/1752966\/jem_20120033.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/209\/7\/1273\/1752966\/jem_20120033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T03:12:49Z","timestamp":1714101169000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/209\/7\/1273\/54616\/Identification-of-broadly-protective-human"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,25]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7,2]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.20120033","relation":{},"ISSN":["1540-9538","0022-1007"],"issn-type":[{"value":"1540-9538","type":"electronic"},{"value":"0022-1007","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6,25]]}}}